"Wait, My Cholesterol Is This High?" Why Half of Patients Skip Medication Despite Serious Risks
Many people are stunned when routine blood work from a health screening comes back showing hypercholesterolemia—an excessive buildup of cholesterol...
Full Article(1000)
Medical AI Can Explain Its Decisions—but Can Clinicians Trust Its Reasons?
Artificial intelligence in medical imaging can analyze brain magnetic resonance imaging scans not only to estimate disease likelihood, but also to...
EZH1 Mutation 'Locks' Cancer-Fighting Genes to Fuel Thyroid Tumors, Study Finds
Cancer cells do not grow simply by switching on genes that drive proliferation; they can also lock away genes that keep...
Celltrion Files for EU Approval of Cosentyx Biosimilar CT-P55, Targeting $6.7 Billion Autoimmune Market
Celltrion announced on the 24th that it has submitted a marketing authorization application to the European Medicines...
GC Green Cross Employees Donate Voices to Produce Audiobooks for Children
GC Green Cross announced on the 24th that it has completed its employee-participation social contribution campaign,...
Korea University Anam Hospital Logs 8,000 Atrial Fibrillation Procedures, a First in South Korea
Korea University Anam Hospital has achieved a cumulative total of 8,000 atrial fibrillation procedures—a nationwide...
Korea’s Healthcare Paradox: Near-Bottom Physician Ranks Meet Top-Tier Life Expectancy
Hospital waiting rooms across South Korea are perpetually packed, where a 30-minute wait remains a routine part of any...
GSK Wins Early FDA Approval for Oral Lung Cancer Drug Jideytro Following $10.6 Billion Nuvalent Acquisition
A new oral therapy is now available for patients with ROS1-positive lung cancer whose disease has progressed following...
Daewoong Pharmaceutical Cuts Off Hospital Sales After Domestic Nabota Vials Surface in the U.S.
Daewoong Pharmaceutical announced on July 23 that it has severed supply transactions with a domestic medical...
HLB Innovation Expands Phase 1 CAR-T Trial Following Clean Early Safety Data
HLB Innovation announced on July 23 that its U.S. subsidiary, Verismo Therapeutics, has expanded the Phase 1 clinical...